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Using static method to measure 
tolmetin solubility at different 
pressures and temperatures 
in supercritical carbon dioxide
Mahboubeh Pishnamazi1,2,3, Samyar Zabihi4, Pegah Sarafzadeh5, Fatemeh Borousan6,7,8, 
Azam Marjani9,10*, Rasool Pelalak11 & Saeed Shirazian3,12
Tolmetin is a non-steroidal anti-inflammatory drug being used to decrease the level of hormones 
which are the reasons for pain, swelling, tiredness, and stiffness for osteoarthritis and rheumatoid 
arthritis cases. We evaluated its solubility in supercritical carbon dioxide (SC-CO2) with the aim of drug 
nanonization, considering temperature and pressure variations between 120 and 400 bar and 308–
338 K, in the experiments. In this way, a PVT solubility cell based on static solubility approach coupled 
with a simple gravimetric procedure was utilized to evaluate the solubility of tolmetin. The solubility 
values between 5.00 × 10−5 and 2.59 × 10−3 mol fraction were obtained for tolmetin depending on the 
pressure and temperature of the cell. The measured data demonstrated a direct correlation between 
pressure and solubility of tolmetin, while the effect of temperature was a dual effect depending on the 
crossover pressure (160 bar). The calculated solubility data were modeled using several semi-empirical 
correlations, and the fitting parameters were calculated using the experimental data via appropriate 
optimization method. The correlated solubility data revealed that the KJ model was the most accurate 
one with an average absolute relative deviation percent (AARD%) of 6.9. Moreover, the carried out 
self-consistency analysis utilizing these correlations illustrated great potential of these models to 
extrapolate the solubility of tolmetin beyond the measured conditions.
In general, it is claimed that using non-steroidal anti-inflammatory drugs (NSAIDs) can enhance the risk of heart 
attack or a stroke for the people who take these drugs unfortunately without warning. Basically, the NSAIDs rise 
the probability risks of significant cardiovascular thrombotic problems, myocardial infarction, and stroke with a 
direct correlation to the duration and dosage of its use. Tolmetin, taken for osteoarthritis, rheumatoid arthritis, 
ankylosing spondylitis and juvenile rheumatoid arthritis, is one among the approved NSAIDs. Tolmetin is a drug 
from the acetic-acid derivative class similar to sulindac, diclofenac, and  indomethacin1,2. Unfortunately, similar 
to the other drugs of NSAIDs family, tolmetin is totally well-tolerated, with some side effects such as headache, 
and dizziness. Moreover, some significant problems can originate from NSAIDs usage such as gastrointestinal 
ulceration and bleeding, increased risk for cardiovascular disease, renal dysfunction, and hypersensitivity reac-
tions including anaphylaxis, exfoliative dermatitis, and Stevens-Johnson  syndrome2. Respecting these facts, it 
seems necessary to enhance the efficacy of this drug concomitant with lowering its required dosage.
OPEN
1Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam. 2The Faculty of 
Pharmacy, Duy Tan University, Da Nang 550000, Viet Nam. 3Department of Chemical Sciences, Bernal Institute, 
University of Limerick, Limerick, Ireland. 4Department of Process Engineering, Research and Development 
Department, Shazand-Arak Oil Refinery Company, Arāk, Iran. 5Department of Chemical Engineering, Faculty 
of Al’Zahra Shiraz, Fars Branch, Technical and Vocational University, Shiraz, Iran. 6Department of Chemistry, 
Yasouj University, Yasouj 75914-353, Iran. 7Incubation Centre of Arak Science and Technology Park, Fanavari 
Atiyeh Pouyandegan Exir Company, Arāk 381314-3553, Iran. 8Incubation Centre of Arak Science and Technology 
Park, Fanavari Arena Exir Sabz Company, Arāk 381314-3553, Iran. 9Department for Management of Science and 
Technology Development, Ton Duc Thang University, Ho Chi Minh City, Viet Nam. 10Faculty of Applied Sciences, 
Ton Duc Thang University, Ho Chi Minh City, Viet Nam. 11Chemical Engineering Faculty, Sahand University of 
Technology, P.O. Box 51335-1996, Sahand New Town, Tabriz, Iran. 12Laboratory of Computational Modeling of 




Scientific Reports |        (2020) 10:19595  | https://doi.org/10.1038/s41598-020-76330-9
www.nature.com/scientificreports/
One of the efficient ways to justify these purposes is the micronization/nanonization process in order to pre-
pare drug particles with small particle size and high surface  area3. In detail, if a drug introduces a low solubility 
in water, it can be subjected to a micronization process to reduce its size to a value below 10 µm3 since according 
to Noyes–Whitney model, particle size reduction can substantially enhance the drug bioavailability of poorly 
soluble substances if their size reduce to micron or nano  level4,5. Moreover, as the drug particles reduce to values 
below 5 µm, a thinner diffusion layer around the particles would be established and the rate of drug absorption 
is not affected anymore by the hydrodynamics in the gastrointestinal tract leading to more effectiveness of the 
drug in the  body6,7. Respecting these facts, several micronization processes are proposed during the past decades 
among which, using supercritical fluid (SCF)-based technologies mostly utilize carbon dioxide  (CO2) as the 
main solvent, is one of the most recently proposed methods to micronize different drugs including  diclofenac8, 
 sulindac9,  fenoprofen10,  piroxicam11, etc.
Regardless of the utilized methods, all of them require the drug solubility in supercritical solvents at vari-
ous operational conditions since these parameters can indicate the required size of the equipment or other 
operating conditions. In this way, several works have been done for measuring solubility of potential drugs 
in supercritical carbon dioxide such as phenylepherin  hydrochloride12,  sulindac13, fluoxetine  hydrochloride14, 
trioctylmethyl  ammonium15,  piroxicam16, etc.17–21. Unfortunately, since measuring the experimental values of 
the solubility for all of the substances at the wide range of temperature and pressure is impossible, it is highly 
required to utilize models and correlations which can simulate solubility values of them under various pressures 
and temperatures such as equations of state (EOS)22,23, artificial neural  network24,25, and, semi-empirical density 
based  correlations26,27. Among the possible modeling approaches, semi-empirical density based correlations are 
one of the widely utilized and examined model since, (a) the required mathematical approach for solving these 
correlations is mostly simple which only needs multiple regression methods, and (b) they just need pressure, 
temperature, and density values at the corresponding pressure and temperature which are quickly and accu-
rately measurable. So, there is no need for estimated parameters during the modeling approach to make them 
more reliable and accurate compared with the aforementioned methods. These correlations have been used and 
validated in literature for prediction of  solubility28,29.
Considering these facts, the solubility of tolmetin in SC-CO2 using a PVT cell linked with well-known gravi-
metric technique is measured under wide ranges of pressures (120–400 bar) and temperatures (308–338 K) for 
the first time since there is no report regarding the solubility of this drug in the literature. This drug was selected 
as the sample drug since there is no report regarding its solubility in SC-CO2 according to the best knowledge of 
the authors. Besides, the calculated solubility results were correlated using five different three-parameter semi-
empirical correlations which are density-based thermodynamic models mainly used for solubility predictions. 
These models include: Bartle et al.30, Garlapati and  Madras27, Mendez-Santiago and Teja (MST)31,  Chrastil32, and 
Kumar-Johnston (KJ)33. For this purpose, a multiple regression method was used to find the fitting parameters 
of each correlation making anyone to reproduce and correlate the solubility of tolmetin in various pressures and 
temperatures. Finally, the extrapolative capability of these correlations was examined using self-consistency test 
since this capability is an undeniable and favorable potential of any predictive method.
Experimental
Materials. Tolmetin  (C15H15NO3), CAS number of 26171-23-3, with molecular weight of 257.29 g gmol−1 
was selected as the sample drug for solubility measurement in the current investigation. Tolmetin was purchased 
from Matrix Scientific (> 95% purity) and was also further treated using  CO2 (purity > 99.8%) at 338  K and 
500 bar to purify  it34.
Solubility tests. A solubility test apparatus was designed and employed in this work to measure the solubil-
ity values of tolmetin at different pressures and temperatures. The apparatus was designed by Fanavari Atiyeh 
Pouyandegan Exir Company (Arak, Iran), and is shown in Fig. 1. The applicability and reliability of the system 
has been validated in our previous publication for measuring Fenoprofen solubility in supercritical  CO234. The 
system operates based on gravimetric method in which the weight of sample before and after the test is meas-
ured to obtain the values of solubility. As shown in Fig. 1, the heart of process is the PVT cell (volume = 0.4 L) 
which is used for the solubility tests at various temperatures and pressures using the designed control system 
connected to the cell. In the liquefaction unit of the process, supercritical  CO2 is generated and sent to PVT cell 
after passing through the booster, filtering, and surge tank units. All experiments were conducted in triplicate, 
and the average values are reported. The detailed description of procedure and solubility measurements can be 
found  elsewhere18,19,21,34.
Results and discussion
Experimental results. In measuring the solubility of tolmetin, eight different pressures (120 to 400 bar, 
interval 40 bar) were set, while the cell temperatures were set at four values, i.e. 308, 318, 328, and 338 K. The 
measurements were repeated three times, and the statistical analysis indicated that the highest value of relative 
standard deviation was 8.6%, and the average relative standard deviation of 6.2% was calculated, confirming the 
acceptable level of reproducibility of the measurements.
The experimental solubility data of tolmetin is shown in Fig. 2 and listed in Table 1 along with standard devia-
tion (SD) values for the measurements. It turned out that the tolmetin solubility values lie between 5.00 × 10−5 
and 2.59 × 10−3 mol fraction (see Table 1). It is clearly observed that the tolmetin solubility is a strong function of 
temperature and pressure. The effect of pressure on solubility is shown to be increasing, however sharper change 
is observed at higher temperatures, e.g. 338 K. On the other hand, the effect of temperature is initially decreas-
ing, and then increasing after a certain point (around 160 bar). This point is known as cross-over point in which 
3
Vol.:(0123456789)
Scientific Reports |        (2020) 10:19595  | https://doi.org/10.1038/s41598-020-76330-9
www.nature.com/scientificreports/
Figure 1.  SC-CO2 drug solubility  apparatus19. Reprinted  from19, Copyright (2020), with permission from 
Elsevier.
Figure 2.  Solubility values of tolmetin.
Table 1.  Solubility of tolmetin. Standard uncertainty (u), are u (T) = 0.1 K and u (P) = 0.35 bar.
P/bar
T/K
308 318 328 338
y SD y SD y SD y SD
120 1.39 × 10−4 1.20 × 10−5 8.83 × 10−5 5.06 × 10−6 6.80 × 10−5 1.46 × 10−6 5.00 × 10−5 2.68 × 10−6
160 2.39 × 10−4 1.89 × 10−5 2.35 × 10−4 1.05 × 10−5 1.86 × 10−5 5.32 × 10−6 1.82 × 10−4 4.99 × 10−6
200 2.97 × 10−4 1.51 × 10−5 3.65 × 10−4 2.21 × 10−5 4.69 × 10−4 3.28 × 10−5 4.93 × 10−4 2.32 × 10−5
240 3.55 × 10−4 1.89 × 10−5 4.70 × 10−4 2.56 × 10−5 6.64 × 10−4 4.16 × 10−5 8.41 × 10−4 5.69 × 10−5
280 4.21 × 10−4 2.84 × 10−5 6.34 × 10−4 4.73 × 10−5 8.74 × 10−4 6.98 × 10−5 1.24 × 10−3 7.65 × 10−5
320 4.98 × 10−4 2.34 × 10−5 7.85 × 10−4 5.52 × 10−5 1.18 × 10−3 1.44 × 10−5 1.65 × 10−3 1.11 × 10−4
360 5.53 × 10−4 4.44 × 10−5 9.40 × 10−4 6.44 × 10−5 1.32 × 10−3 7.81 × 10−5 2.06 × 10−3 1.72 × 10−4
400 6.30 × 10−4 5.40 × 10−5 1.11 × 10−3 7.17 × 10−5 1.71 × 10−3 1.09 × 10−4 2.59 × 10−3 2.06 × 10−4
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the influence of temperature on tolmetin solubility changes. In fact, as PVT cell pressure is kept below 160 bar, 
an enhancement in the cell temperature caused a reduction in tolmetin solubility while in the pressures greater 
than this value, enhancing temperature may more effectively activate the sublimation pressure modification 
which can compensate the density decrement effect due to temperature enhancement, consequently causes more 
solubility of tolmetin. Furthermore, the observation of cross-over pressure point in the solubility data confirm 
the reliability of data for tolmetin solubility, as reported by Foster et al.35.
Modeling. The finding results of solubility are correlated via five semi-empirical thermodynamic equations 
for predicting tolmetin solubility. The modelling results are shown in the Table 2 and Fig. 3. Measuring tolmetin 
solubility values applying the fitting parameters listed in Table 2 for all models, demonstrated the modeling 
possibility of the solubility results of tolmetin include AARD% of about 11.3%, 10.2%, 6.9%, 12.3% and 12.1% 
for Bartle et al., Mendez-Santiago-Teja, Kumar and Johnstone (KJ), Chrastil, and Garlapati and Madras models, 
respectively.
A considerable advantage of the examined models especially Bartle et al., and Chrastil model is their ability 
to predict the total enthalpy, enthalpy of vaporization and solvation enthalpy as follow:
R is the gas universal constant.
Besides the correlative capability, extrapolative potential is the other important advantage of any correlation 
or model. Respecting that, the extrapolative capability of the examined models was investigated performing self-
consistency test (see Figs. 3 and 4). The results demonstrated that the solubility results could satisfy the linear 
behavior for all the examined isotherms and isobars in the current investigation regardless of their values. So, it 
can be concluded that it would be possible to estimate the solubility of tolmetin in the temperatures and pressures 
out of the calculated range since the solubility data obey a simple linear behavior.
Conclusions
Measuring tolmetin solubility in SC-CO2 at various pressures and temperatures is the main objective of the 
current investigation. Then, a static approach linked to a simple gravimetric approach was utilized to calculate 
the solubility of tolmetin with the assist of PVT cell. The measurement revealed that tolmetin solubility was 
between 5.00 × 10−5 and 2.59 × 10−3 based on mole fraction. The measurements demonstrated that it is possible to 
enhance the solubility of tolmetin by increasing pressure, while increasing temperature can lead to two different 
trends of increasing and decreasing. In detail, since the temperature can have influence on density and sublima-
tion pressure concomitantly, but act in opposite directions, it would be the net of these two challenging factors 
which demonstrated that temperature with decreasing or increasing result. The point where the temperature 
influences changes called cross-over pressure which for the current the system was a transient region between 
120–160 bar where for the pressures of 120 and 160 bar, decreasing the density because of the increasing the 
temperature is dominant while for the pressures upper than 160 bar, sublimation pressure modification would 
be dominant leading to an enhancement in the solubility of tolmetin in SC-CO2. Besides the experimental 
measuring of tolmetin solubility, the measured values were correlated utilizing five density-based correlations 
since it would not be possible to calculate the solubility of tolmetin in all the ranges of pressure and temperature. 
The correlation results revealed that among the examined models, KJ led to the lowest AARD% value of 6.9% 
while the other models leading higher AARD%, although they still introduce a great admissible precision. The 
other important privilege is the extrapolative ability of these models which can be examined by performing self-
consistency tests. The performed self-consistency test revealed a great extrapolative capability of these models 
since the measured solubility data for all the examined temperatures and pressures justify a straight line that 
shows the other thermodynamic conditions beyond the considered ranges can justify the current line which 
means the extrapolative ability of these models.
(1)Hsub = −Rb → 78.8 kJ/mol
(2)Htotal = −Ra → 59.4 kJ/mol
(3)Hsolvation = Htotal −Hsub → −19.4 kJ/mol
Table 2.  Fitting parameters of semi-empirical density-based correlations. a AARD% = 100 × ∑ ((ycalc − yexp)/
yexp).
Models (AARD%)a Mathematical equation of model
Constants
a b c







T/K + c · (ρ − ρref )
25.9 − 9480 0.0122





= a+ b · T/K + c · ρ/kg ·m−3 12,662- 27.205 3.93
Kumar and Johnstone (6.9%) ln y = a+ b
/
T/K + c · ρ /kmol ·m
−3 7.71 − 7094.4 0.361
Chrastil (12.3%) ln s/kg ·m−3 = a+ b
/
T/K + c · ln ρ/kg ·m
−3 − 7149.3 24.404 7.03
Garlapati and Madras (12.1%) ln y = a+ b/T/K+ c ln(ρ/kg ·m−3 T/K) − 66.58 − 5202 6.025
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Figure 3.  Tolmetin solubility results applying, (a) Bartle et al. model, (b) Chrastil, (c) MST and (d) KJ model.
Figure 4.  Self-consistency test utilizing MST model.
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